Workflow
荣泰转债
icon
Search documents
荣泰健康: 上海荣泰健康科技股份有限公司关于实施“荣泰转债”赎回暨摘牌的第一次提示性公告
Zheng Quan Zhi Xing· 2025-08-26 18:15
债券代码:113606 债券简称:荣泰转债 上海荣泰健康科技股份有限公司 关于实施"荣泰转债"赎回暨摘牌的第一次提示性 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 证券代码:603579 证券简称:荣泰健康 公告编号:2025-053 ? 赎回登记日:2025 年 9 月 11 日 ? 赎回价格:102.1713 元/张 ? 赎回款发放日:2025 年 9 月 12 日 ? 最后交易日:2025 年 9 月 8 日 截至2025年8月26日收市后,距离9月8日("荣泰转债"最后交易日)仅剩 ? 最后转股日:2025 年 9 月 11 日 截至2025年8月26日收市后,距离9月11日("荣泰转债"最后转股日)仅 剩12个交易日,9月11日为"荣泰转债"最后一个转股日。 ? 本次提前赎回完成后,"荣泰转债"将自 2025 年 9 月 12 日起在上海证 券交易所摘牌。 ? 投资者所持"荣泰转债"除在规定时限内通过二级市场继续交易或按照 应计利息 2.1713 元/张(即合计 102.1713 元/张)被 ...
荣泰健康: 上海荣泰健康科技股份有限公司关于实施“荣泰转债”赎回暨摘牌的公告
Zheng Quan Zhi Xing· 2025-08-25 19:12
关于实施"荣泰转债"赎回暨摘牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 证券代码:603579 证券简称:荣泰健康 公告编号:2025-052 转债代码:113606 转债简称:荣泰转债 上海荣泰健康科技股份有限公司 重要内容提示: ? 证券停复牌情况:适用 因提前赎回"荣泰转债",本公司的相关证券停复牌情况如下: 停牌 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | | | | | 期间 | | | 可转债债券停 牌 "荣泰转债"最后交易日)仅 截至 2025 年 8 月 25 日收市后,距离 9 月 11 日("荣泰转债"最后转股日) 仅剩 13 个交易日,9 月 11 日为"荣泰转债"最后一个转股日。 ? 本次提前赎回完成后,"荣泰转债"将自 2025 年 9 月 12 日起在上海证券交易 所摘牌。 ? 投资者所持"荣泰转债"除在规定时限内通过二级市场继续交易或按照 23.07 元/股的转 ...
上海荣泰健康科技股份有限公司关于“荣泰转债”转股数量累计达到转股前公司已发行股份总额10%暨股份变动公告
Core Viewpoint - The announcement details the cumulative conversion of "Rongtai Convertible Bonds" into the company's common stock, indicating significant shareholder engagement and adjustments in conversion prices due to profit distribution plans [2][4][5][6][7][8]. Group 1: Convertible Bond Conversion Status - As of August 18, 2025, a total of RMB 338,153,000 worth of "Rongtai Convertible Bonds" has been converted into 14,654,387 shares, representing 10.4674% of the company's total shares before conversion [2][8]. - The remaining unconverted "Rongtai Convertible Bonds" amount to RMB 261,847,000, which is 43.6412% of the total issuance [2][8]. Group 2: Convertible Bond Issuance Overview - The company issued 6 million convertible bonds on October 30, 2020, with a total value of RMB 60 million and a maturity of 6 years, featuring a tiered interest rate structure [3]. - The bonds were listed on the Shanghai Stock Exchange on November 20, 2020, under the name "Rongtai Convertible Bonds" with the code "113606" [3]. Group 3: Conversion Price Adjustments - The initial conversion price was set at RMB 33.32 per share, which has been adjusted multiple times due to annual profit distribution plans, with the latest adjustment reducing the price to RMB 23.07 per share effective June 12, 2025 [4][5][6][7].
19日投资提示:东时转债复牌
集思录· 2025-08-18 14:15
荣泰转债:强赎 | 转债代码 | 转债名称 | 现价 | 强赎价 | 最后交易日 | 最后转股日 | 转股价值 | 剩余规模 | 转债占正股 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | (亿元) | 流通市值比 | | 123156 | 博汇转债 | 177.000 | 100.020 | 2025-08-14 | 2025-08-19 | 177.25 | 1.458 | 3.60% | | 123063 | 大禹转债 | 145.250 | 100.200 | 2025-08-15 | 2025-08-20 | 147.00 | 0.103 | 0.22% | | 127035 | 濮耐转债 | 178.903 | 100.906 | 2025-08-15 | 2025-08-20 | 181.67 | 0.076 | 0.11% | | 118023 | 广大转债 | 126.400 | 100.866 | 2025-08-19 | 2025-08-22 | 126.97 | 0.460 | 0.63 ...
金融工程定期:8月转债配置:转债估值偏贵,看好偏股低估风格
KAIYUAN SECURITIES· 2025-08-17 05:16
Quantitative Models and Construction Methods Model 1: Convertible Bond Valuation Model - **Model Name**: Convertible Bond Valuation Model - **Model Construction Idea**: The model aims to compare the valuation of convertible bonds with their underlying stocks using a time-series comparable valuation metric called "100 Yuan Conversion Premium Rate" and the median of "Adjusted YTM - Credit Bond YTM" to measure the relative allocation value between debt-biased convertible bonds and credit bonds[4][5][15] - **Model Construction Process**: - **100 Yuan Conversion Premium Rate**: Fit the relationship curve between the conversion premium rate and conversion value in the cross-sectional space at each time point, and substitute the conversion value = 100 into the fitting formula to obtain the "100 Yuan Conversion Premium Rate" - Formula: $$ y_{i}=\alpha_{0}+\,\alpha_{1}\cdot\,{\frac{1}{x_{i}}}+\epsilon_{i} $$ where \( y_{i} \) is the conversion premium rate of the i-th convertible bond, and \( x_{i} \) is the conversion value of the i-th convertible bond[43] - **Adjusted YTM - Credit Bond YTM**: Adjust the YTM of debt-biased convertible bonds by stripping out the impact of conversion terms - Formula: $$ \text{Adjusted YTM} = \text{Convertible Bond YTM} \times (1 - \text{Conversion Probability}) + \text{Expected Conversion Annualized Yield} \times \text{Conversion Probability} $$ The conversion probability is calculated using the BS model, substituting the closing price of the underlying stock, option exercise price, stock volatility, remaining term, and discount rate to calculate the conversion probability \( N(d2) \)[44] - **Model Evaluation**: The model provides a systematic approach to evaluate the relative allocation value of convertible bonds compared to their underlying stocks and credit bonds[15] Model 2: Convertible Bond Comprehensive Valuation Factor - **Model Name**: Convertible Bond Comprehensive Valuation Factor - **Model Construction Idea**: The model combines the deviation of the conversion premium rate and the theoretical value deviation (Monte Carlo model) to construct a comprehensive valuation factor for convertible bonds[6][19] - **Model Construction Process**: - **Conversion Premium Rate Deviation**: - Formula: $$ \text{Conversion Premium Rate Deviation} = \text{Conversion Premium Rate} - \text{Fitted Conversion Premium Rate} $$ - **Theoretical Value Deviation (Monte Carlo Model)**: - Formula: $$ \text{Theoretical Value Deviation} = \frac{\text{Convertible Bond Closing Price}}{\text{Theoretical Value}} - 1 $$ The Monte Carlo model fully considers the conversion, redemption, downward revision, and repurchase terms of convertible bonds, simulating 10,000 paths at each time point and using the same credit term interest rate as the discount rate to calculate the theoretical value of the convertible bond[20] - **Comprehensive Valuation Factor**: - Formula: $$ \text{Convertible Bond Comprehensive Valuation Factor} = \text{Rank}(\text{Conversion Premium Rate Deviation}) + \text{Rank}(\text{Theoretical Value Deviation (Monte Carlo Model)}) $$ - **Model Evaluation**: The comprehensive valuation factor performs well in the overall, balanced, and debt-biased convertible bonds, while the theoretical value deviation (Monte Carlo model) performs better in equity-biased convertible bonds[19][20] Model 3: Convertible Bond Style Rotation Model - **Model Name**: Convertible Bond Style Rotation Model - **Model Construction Idea**: The model uses convertible bond momentum and volatility deviation as market sentiment capture indicators to construct a convertible bond style rotation portfolio, with bi-weekly rebalancing[7][26] - **Model Construction Process**: - **Market Sentiment Capture Indicators**: - Formula: $$ \text{Convertible Bond Style Market Sentiment Capture Indicator} = \text{Rank}(\text{Convertible Bond 20-Day Momentum}) + \text{Rank}(\text{Volatility Deviation}) $$ - **Style Rotation Position Calculation**: - Example Calculation: | | Convertible Bond Equity-Biased Low Valuation | Convertible Bond Balanced Low Valuation | Convertible Bond Debt-Biased Low Valuation | | --- | --- | --- | --- | | Equal Weight Index | 1 | 2 | 3 | | Volatility Deviation Ranking | 2 | 1 | 3 | | Market Sentiment Capture Indicator | 3 | 3 | 6 | | Style Rotation Position | 50% | 50% | 0% | - **Model Evaluation**: The style rotation model effectively captures market sentiment and allocates positions accordingly, showing superior performance compared to the equal-weight index[26][27][28] Model Backtesting Results Convertible Bond Valuation Model - **100 Yuan Conversion Premium Rate**: Rolling three-year percentile at 98.70%, rolling five-year percentile at 94.90%[4][15] - **Adjusted YTM - Credit Bond YTM**: Current median at -2.36%[5][15] Convertible Bond Comprehensive Valuation Factor - **Equity-Biased Convertible Bond Low Valuation Index**: - Annualized Return: 26.10% - Annualized Volatility: 20.55% - Maximum Drawdown: -22.94% - IR: 1.27 - Calmar Ratio: 1.14 - Monthly Win Rate: 62.22%[23] - **Balanced Convertible Bond Low Valuation Index**: - Annualized Return: 14.80% - Annualized Volatility: 11.82% - Maximum Drawdown: -15.95% - IR: 1.25 - Calmar Ratio: 0.93 - Monthly Win Rate: 62.22%[23] - **Debt-Biased Convertible Bond Low Valuation Index**: - Annualized Return: 13.37% - Annualized Volatility: 9.43% - Maximum Drawdown: -17.78% - IR: 1.42 - Calmar Ratio: 0.75 - Monthly Win Rate: 57.78%[23] Convertible Bond Style Rotation Model - **Convertible Bond Style Rotation**: - Annualized Return: 25.27% - Annualized Volatility: 16.68% - Maximum Drawdown: -15.89% - IR: 1.51 - Calmar Ratio: 1.59 - Monthly Win Rate: 65.56%[32] - **Convertible Bond Low Valuation Equal Weight Index**: - Annualized Return: 14.71% - Annualized Volatility: 10.97% - Maximum Drawdown: -15.48% - IR: 1.34 - Calmar Ratio: 0.95 - Monthly Win Rate: 61.11%[32] - **Convertible Bond Equal Weight Index**: - Annualized Return: 9.75% - Annualized Volatility: 11.66% - Maximum Drawdown: -20.60% - IR: 0.84 - Calmar Ratio: 0.47 - Monthly Win Rate: 60.00%[32]
荣泰健康:关于可转债预计满足赎回条件的提示性公告
Zheng Quan Ri Bao· 2025-08-11 11:48
Core Viewpoint - Rongtai Health announced that its stock price has met the conditions for a potential redemption of its convertible bonds, which may occur if certain price thresholds are maintained over a specified period [2] Summary by Relevant Sections - **Stock Performance** - From July 29, 2025, to August 11, 2025, the company's stock has closed at or above 130% of the current conversion price (29.99 yuan/share) for 10 trading days [2] - **Redemption Conditions** - If the stock price remains at or above 130% of the conversion price for 5 out of the next 20 trading days, it will trigger the conditional redemption clause for the "Rongtai Convertible Bonds" [2] - **Board Meeting and Disclosure** - The company will hold a board meeting on the triggering date to decide whether to redeem all or part of the unconverted convertible bonds at face value plus accrued interest, and will fulfill its information disclosure obligations promptly [2]
中证转债指数高开0.07%。再22转债涨4.8%,山河转债涨2.7%,精达转债、华懋转债涨逾1%;帝欧转债跌1.5%,荣泰转债跌近1%。
news flash· 2025-07-01 01:29
Group 1 - The Zhongzheng Convertible Bond Index opened high at 0.07% [1] - The 22 Convertible Bond increased by 4.8%, while the Shanhe Convertible Bond rose by 2.7% [1] - The Jingda Convertible Bond and Huamao Convertible Bond both increased by over 1% [1] Group 2 - The Diou Convertible Bond decreased by 1.5%, and the Rongtai Convertible Bond fell by nearly 1% [1]
荣泰健康: 上海荣泰健康科技股份有限公司关于可转换公司债券跟踪评级结果的公告
Zheng Quan Zhi Xing· 2025-06-24 17:13
Core Points - The company, Shanghai Rongtai Health Technology Co., Ltd., has maintained its credit rating of "AA-" for both its corporate and convertible bonds, with a stable outlook [1][2] - The tracking rating was conducted by Shanghai New Century Credit Rating Co., Ltd., based on a comprehensive analysis of the company's operational status and related industry [2] Group 1 - Previous bond rating was "AA-", with a stable outlook [1] - Current bond rating remains "AA-", with a stable outlook [2] - The tracking rating report was issued on June 23, 2025, and is available on the Shanghai Stock Exchange website [2]
上海荣泰健康科技股份有限公司2024年年度权益分派实施公告
Core Viewpoint - Shanghai Rongtai Health Technology Co., Ltd. announced its 2024 annual profit distribution plan, proposing a cash dividend of RMB 3.50 per 10 shares (including tax) to all shareholders, with the total cash dividend amount adjusted to RMB 61,282,903.85 (including tax) due to changes in the total share capital from convertible bond conversions [2][13][16]. Distribution Plan - The distribution year is set for 2024, and the distribution will be made to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the registration date [3]. - The company will not issue bonus shares or increase capital reserves, and any undistributed profits will be carried forward to future years [4][13]. Dividend Calculation - The cash dividend per share is calculated as follows: (175,094,011 shares participating in distribution × RMB 0.35) ÷ 177,397,211 total shares ≈ RMB 0.3455 per share [6][16]. - The reference price for ex-dividend trading will be adjusted based on the formula: (previous closing price - cash dividend) [5][6]. Tax Implications - For individual shareholders holding unrestricted shares, dividends are subject to different tax treatments based on the holding period, with a maximum tax rate of 20% for shares held for less than one month [8][10]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply to dividends [10]. Convertible Bond Adjustment - The conversion price for the company's convertible bonds ("Rongtai Convertible Bonds") will be adjusted from RMB 23.42 per share to RMB 23.07 per share due to the cash dividend distribution [19][24]. - The adjustment will take effect on June 12, 2025, and the bonds will stop conversion from June 5 to the registration date [24].
荣泰健康: 上海荣泰健康科技股份有限公司关于实施2024年度权益分派时“荣泰转债”停止转股的提示性公告
Zheng Quan Zhi Xing· 2025-05-29 09:56
Group 1 - The company will stop the conversion of its convertible bonds ("Rongtai Convertible Bonds") during the period of the 2024 annual equity distribution, specifically from June 5, 2025, until the equity distribution registration date [1][2] - The total registered share capital, excluding shares in the repurchase account, will be the basis for the equity distribution, with a cash dividend of RMB 3.50 per 10 shares (including tax), without any capital increase or stock distribution [1][2] - Holders of the convertible bonds wishing to enjoy the equity distribution must convert their bonds before June 4, 2025 [2] Group 2 - The company has announced the suspension of bond conversion during the equity distribution period, with resumption on the first trading day after the registration date [2] - The company will disclose the implementation announcement of the equity distribution and the adjustment of the bond conversion price through designated information disclosure media [2] - The board of directors guarantees the accuracy and completeness of the announcement content, taking legal responsibility for any false or misleading statements [1]